Home
About
News & Events

News & Events

Latest events March 24, 2026

ECM Remodeling and Precision Trials in Pulmonary Diseases | Webinar

From Heterogeneity to Biology: ECM Remodeling and Precision Trials in Pulmonary Diseases Join this ECM Pharmacology Symposium to explore whether current approaches truly capture the underlying biology of pulmonary diseases such as COPD and lung cancer. This session focuses on extracellular matrix (ECM) remodeling as a central disease mechanism, its role in disease heterogeneity, and […]

Read article

Spring/Summer Conference Season (Q1-Q2)

Find an overview of the conferences Nordic Bioscience will be attending in Q1-Q2. This year’s conference season has begun, and we look forward to the upcoming months with conferences in Europe, North America and Asia. Our team will share our newest insights from various disease areas in verbal presentations and posters, and we look forward […]

Read article

Best of 2025 Publications Digest

Welcome to the Best of 2025 Publication Digest! Once again, we invite you to take a look at the best publications of the past year. We have collected some of the best papers in a range of disease areas that underline our continuous efforts towards developing new and better assays that aim to improve treatment […]

Read article

Latest events March 10, 2026

Fibroblast Activity and ECM Turnover | Webinar

Fibroblast Activity and ECM Turnover: Biomarkers for Outcomes in Fibrosis and Cancer Overview Join this webinar to explore why the extracellular matrix (ECM) sits at the center of chronic disease and why fibroblast activity is emerging as a practical, quantifiable lever for prognosis and drug development across fibrosis and oncology. We will highlight key takeaways from […]

Read article

Latest events January 22, 2026

AD/PD 2026

Nordic Bioscience’s neurology team will attend this year’s AD/PD conference in Copenhagen, Denmark. It will take place from March 17-21 and revolve around Alzheimer’s and Parkinson’s diseases. Our team will bring four posters, which will cover the following topics: There will also be a oral presentation on how the blood-based biomarker TAU-C is related to […]

Read article

Latest events January 21, 2026

ECCO 2026

Nordic Bioscience’s gastroenterology team will be attending ECCO 2026, held February 18–21, 2026, in Stockholm, Sweden. As one of the most influential congresses in inflammatory bowel disease, ECCO provides a focused setting for scientific exchange across clinical practice, translational research, and drug development. At this year’s meeting, we will be exhibiting and highlighting CPa9-HNE™, our […]

Read article

Pliant Therapeutics Publishes Positive Data From Their INTEGRIS-IPF Phase 2a Trial of Bexotegrast Featuring PRO-C3 Biomarker

January 24, 2023

Read article

1 … 3 4 5 6 7 8

Upcoming events

ECM Remodeling and Precision Trials in Pulmonary Diseases | Webinar

April 21, 2026

Online

View event

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

Cardiovascular diseases

Dermatology

Gastrointestinal diseases

Hepatic diseases

Kidney diseases

Neuroscience

Obesity

Oncology

Respiratory diseases

Rheumatic diseases

What we offer

Biomarker portfolio

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

Our services

Lab solutions

Biomarker Solutions

Biomarker Portfolio

Why Biomarkers?

Kit in a Box

Measure specific protein fragments

Our technology

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

About Nordic Bioscience

Who we are

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

Cardiovascular diseases

Dermatology

Gastrointestinal diseases

Hepatic diseases

Kidney diseases

Neuroscience

Obesity

Oncology

Respiratory diseases

Rheumatic diseases

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

Biomarker Solutions

Biomarker Portfolio

Why Biomarkers?

Kit in a Box

Biomarker Solutions

Biomarker Portfolio

Kit in a Box

Why Biomarkers?

News & Events

ECM Remodeling and Precision Trials in Pulmonary Diseases | Webinar

Spring/Summer Conference Season (Q1-Q2)

Best of 2025 Publications Digest

Fibroblast Activity and ECM Turnover | Webinar

AD/PD 2026

ECCO 2026

News

PRESS RELEASE: Nordic Bioscience Secures Trademarks for Vital Biomarkers and Advanced Technology

Latest Publication Reveals Insights on Collagen Turnover Biomarkers in Hemophilia A Patients

Morten Karsdal, CEO of Nordic Bioscience, Reflects on the PRO-C3 Biomarker in Tumor Fibrosis FDA Letter of Support

PRESS RELEASE: Nordic Bioscience Receives Letter of Support From the FDA for the PRO-C3 Biomarker in Tumor Fibrosis

Morten Karsdal, CEO of Nordic Bioscience, Receives the Arthur D. Little Nordic Life Science Award

Pliant Therapeutics Publishes Positive Data From Their INTEGRIS-IPF Phase 2a Trial of Bexotegrast Featuring PRO-C3 Biomarker

Upcoming events

ECM Remodeling and Precision Trials in Pulmonary Diseases | Webinar